NASDAQ:APDN Applied DNA Sciences (APDN) Stock Price, News & Analysis $2.26 -0.40 (-14.88%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$2.03 -0.23 (-10.35%) As of 03/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends About Applied DNA Sciences Stock (NASDAQ:APDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Applied DNA Sciences alerts:Sign Up Key Stats Today's Range$1.95▼$2.7650-Day Range$0.05▼$2.2652-Week Range$1.95▼$522.00Volume620,301 shsAverage Volume101,903 shsMarket Capitalization$124.73 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingBuy Company OverviewApplied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More… Remove Ads Applied DNA Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScoreAPDN MarketRank™: Applied DNA Sciences scored higher than 13% of companies evaluated by MarketBeat, and ranked 167th out of 175 stocks in the industrial products sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageApplied DNA Sciences has received no research coverage in the past 90 days.Read more about Applied DNA Sciences' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 7.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Applied DNA Sciences' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.45% of the float of Applied DNA Sciences has been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 46.52%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.45% of the float of Applied DNA Sciences has been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 46.52%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.48 News SentimentApplied DNA Sciences has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Applied DNA Sciences this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.17% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 22.22% of the stock of Applied DNA Sciences is held by institutions.Read more about Applied DNA Sciences' insider trading history. Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Stock News HeadlinesApplied DNA Sciences trading halted, news pendingMarch 13 at 11:48 PM | markets.businessinsider.comApplied DNA Sciences announces 1-for-50 reverse stock splitMarch 12 at 10:14 PM | markets.businessinsider.comYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.March 15, 2025 | American Alternative (Ad)Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)February 28, 2025 | markets.businessinsider.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call TranscriptFebruary 15, 2025 | insidermonkey.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call TranscriptFebruary 15, 2025 | msn.comApplied DNA Sciences fails to secure quorum at meetingFebruary 14, 2025 | msn.comApplied DNA signals growth with GMP facility launch and LineaRx focus in 2025February 14, 2025 | msn.comSee More Headlines APDN Stock Analysis - Frequently Asked Questions How have APDN shares performed this year? Applied DNA Sciences' stock was trading at $0.2040 at the start of the year. Since then, APDN stock has increased by 1,007.8% and is now trading at $2.26. View the best growth stocks for 2025 here. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its quarterly earnings data on Thursday, February, 13th. The technology company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.24. Applied DNA Sciences had a negative net margin of 228.12% and a negative trailing twelve-month return on equity of 101.57%. When did Applied DNA Sciences' stock split? Applied DNA Sciences shares reverse split on Thursday, April 25th 2024. The 1-20 reverse split was announced on Thursday, April 25th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' top institutional shareholders include Geode Capital Management LLC (0.76%), Connective Capital Management LLC (0.32%), Millennium Management LLC (0.24%) and Concourse Financial Group Securities Inc.. View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings2/13/2025Today3/14/2025Next Earnings (Estimated)5/09/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Testing laboratories Sub-IndustryBusiness Services Current SymbolNASDAQ:APDN CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees70Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside-33.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($5.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,990,000.00 Net Margins-228.12% Pretax Margin-230.79% Return on Equity-101.57% Return on Assets-62.43% Debt Debt-to-Equity RatioN/A Current Ratio4.72 Quick Ratio4.53 Sales & Book Value Annual Sales$3.74 million Price / Sales33.38 Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / Book7.79Miscellaneous Outstanding Shares55,189,000Free Float55,095,000Market Cap$124.73 million OptionableOptionable Beta0.43 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:APDN) was last updated on 3/15/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied DNA Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
